Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.

  title={Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.},
  author={Volker Ziller and Matthias Kalder and Ute S. Albert and W Holzhauer and May Ziller and U. F. Wagner and Peyman Hadji},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  volume={20 3},
BACKGROUND The level of adherence of various pharmacological therapies in chronic diseases varies, but is predominantly low. With tamoxifen (TAM), 23% and 50% nonadherence after 1 and 4 years have been reported. Day-to-day clinical observation suggests that adherence may even be lower with aromatase inhibitors, but limited data exist on the situation in daily clinical routine. The aim of this study was to evaluate the rate of adherent patients in a randomly selected sample of postmenopausal… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 116 extracted citations

Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review.

European journal of cancer care • 2012
View 11 Excerpts
Highly Influenced

A social cognitive theory-based framework for monitoring medication adherence applied to endocrine therapy in breast cancer survivors

2018 IEEE EMBS International Conference on Biomedical & Health Informatics (BHI) • 2018
View 1 Excerpt

Similar Papers

Loading similar papers…